Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study
F. Vermeer et al., Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study, HEART, 82(4), 1999, pp. 426-431
Citations number
29
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective-To assess the safety and feasibility of acute transport followed
by rescue percutaneous transluminal coronary angioplasty (PTCA) or primary
PTCA in patients with acute myocardial infarction initially admitted to a h
ospital without PTCA facilities.
Design-In a multicentre randomised open trial, three regimens of treatment
of acute large myocardial infarction were compared for patients admitted to
hospitals without angioplasty facilities: thrombolytic treatment with alte
plase (75 patients), alteplase followed by transfer to the PTCA centre and
(if indicated) rescue PTCA (74 patients), or transfer for primary PTCA (75
patients).
Results-Between 1995 and 1997 224 patients were included. Baseline characte
ristics were distributed evenly. Transport to the PTCA centre was without s
evere complications in all patients. Mean (SD) delay from onset of symptoms
to randomisation was 130 (75) minutes and from randomisation to angiograph
y 90 (25) minutes. Death or recurrent infarction within 42 days occurred in
12 patients in the thrombolysis group, in 10 patients in the rescue PTCA g
roup, and in six patients in the primary PTCA group. These differences were
not significant.
Conclusions-Acute transfer for rescue PTCA or primary PTCA in patients with
extensive myocardial infarction is feasible and safe. Efficacy of rescue P
TCA or primary PTCA in this setting will have to be tested in larger series
before this approach can be implemented as "routine treatment" for patient
s with extensive myocardial infarction.